PharmacoFore, Inc.
130 Lytton Avenue
Suite 100
Palo Alto
California
United States
Tel: 650-641-0000
5 articles about PharmacoFore, Inc.
-
PharmacoFore, Inc. Secures $10 Million in Equity Financing From Founders Fund
12/28/2011
-
PharmacoFore, Inc. Announces Appointment of Chief Medical Officer and Vice President of Intellectual Property
6/27/2011
-
PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 Biotechnology Industry Organization (BIO) Business Forum During the Annual Bio
6/24/2011
-
PharmacoFore, Inc. Announces Sponsorship of the 2011 CLAAD National Prescription Drug Abuse Prevention Policy Consensus Meeting on November 29, 2011 in Washington, DC
5/6/2011
-
PharmacoFore, Inc.'s Bio-Activated Molecular Delivery(TM) and MPAR(TM) Technologies to be Introduced by Dr. Lynn Webster at the 27th Annual American Academy of Pain Medicine Meeting
3/28/2011